Armata Pharmaceuticals (ARMP) Assets (2016 - 2018)
Historic Assets for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to $10.6 million.
- Armata Pharmaceuticals' Assets fell 2294.46% to $10.6 million in Q3 2018 from the same period last year, while for Sep 2018 it was $10.6 million, marking a year-over-year decrease of 2294.46%. This contributed to the annual value of $11.1 million for FY2017, which is 3864.38% down from last year.
- Latest data reveals that Armata Pharmaceuticals reported Assets of $10.6 million as of Q3 2018, which was down 2294.46% from $11.7 million recorded in Q2 2018.
- Armata Pharmaceuticals' Assets' 5-year high stood at $38.6 million during Q1 2015, with a 5-year trough of $10.6 million in Q3 2018.
- Over the past 5 years, Armata Pharmaceuticals' median Assets value was $28.3 million (recorded in 2016), while the average stood at $24.5 million.
- In the last 5 years, Armata Pharmaceuticals' Assets surged by 1005.0% in 2015 and then crashed by 4939.32% in 2017.
- Armata Pharmaceuticals' Assets (Quarter) stood at $28.6 million in 2014, then increased by 10.05% to $31.5 million in 2015, then tumbled by 42.36% to $18.2 million in 2016, then crashed by 38.64% to $11.1 million in 2017, then decreased by 4.66% to $10.6 million in 2018.
- Its Assets stands at $10.6 million for Q3 2018, versus $11.7 million for Q2 2018 and $14.4 million for Q1 2018.